z-logo
Premium
Immunohistochemical characterization of the cellular infiltrate in localized scleroderma
Author(s) -
Xie Yong,
Zhang Xiaoyong,
Wakasugi Shoji,
Makino Takamitsu,
Inoue Yuji,
Ihn Hironobu
Publication year - 2008
Publication title -
international journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 93
eISSN - 1365-4632
pISSN - 0011-9059
DOI - 10.1111/j.1365-4632.2008.03615.x
Subject(s) - pathology , medicine , scleroderma (fungus) , pathogenesis , cd8 , cd3 , monoclonal antibody , immunohistochemistry , connective tissue , il 2 receptor , fibrosis , connective tissue disease , antibody , immunology , t cell , immune system , autoimmune disease , disease , inoculation
Background  Localized scleroderma is a connective tissue disorder with hardening of the skin and fibrosis of the affected tissue as the most prominent features. The etiology of localized scleroderma is still unknown, but immunologic factors may play an important role in the pathogenesis. This study was performed to determine the immunohistochemical features of the cellular infiltrate in localized scleroderma. Methods  Skin samples were obtained from six patients by 6‐mm punch biopsy. The samples were stained with monoclonal antibodies against CD1a, CD3, CD4, CD8, CD20, CD25, CD30, and CD57. The number of cells stained with each monoclonal antibody was calculated. Results  There were more CD1a+, CD3+, CD4+, CD8+, CD20+, CD25+, and CD57+ cells in the dermal infiltrate in localized scleroderma relative to those in normal controls. The numbers of CD1a+, CD3+, CD4+, CD8+, and CD57+ cells in localized scleroderma were significantly greater than those in normal skin ( P  < 0.05). The number of CD30+ cells in localized scleroderma was almost the same as that in normal skin. Conclusions  This study reveals that T lymphocytes, Langerhans cells, and natural killer cells may play important roles in the pathogenesis of localized scleroderma.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here